- 3-MMC
- Metaphedrone
- 3-Methylmethcathinone
Power, JD; McGlynn, P; Clarke, K; McDermott, S; Kavanagh, PV; O’Brien, J. The analysis of substituted cathinones. Part 1: Chemical analysis of 2-, 3-, and 4-methylmethcathinone. Forensic Sci. Int., 10 Oct 2011, 212 (1–3), 6–12. 1.1 MB. https://doi.org/10.1016/j.forsciint.2011.04.020
EMCDDA. New drugs in Europe, 2012, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2013. 773 kB. #52
Luethi, D; Kolaczynska, KE; Docci, L; Krähenbühl, S; Hoener, MC; Liechti, ME. Pharmacological profile of mephedrone analogs and related new psychoactive substances. Neuropharmacology, 15 May 2018, 134 (A), 4-12. 1.8 MB. https://doi.org/10.1016/j.neuropharm.2017.07.026 #3-MMC
EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.
Adamowicz, P; Zuba, D. Discrimination among designer drug isomers by chromatographic and spectrometric methods. In Chromatographic Techniques in the Forensic Analysis of Designer Drugs; Kowalska, T; Sajewicz, M; Sherma, J, Eds., CRC Press, Taylor & Francis Group, 1 Jan 2018; pp 211–232. 1.1 MB.
Grumann, C; Auwärter, V. Separation of positional isomers of nine 2-phenethylamine-derived designer drugs by liquid chromatography-tandem mass spectrometry. Drug Test. Anal., 1 Jul 2018, 10 (7), 1184–1191. 861 kB. https://doi.org/10.1002/dta.2371 #3-MMC LC,MS
Chapman, SJ. Novel Psychoactive Spectra: NMR of (mostly) Novel Psychoactive Substances. BLOTTER, 25 Jun 2018, 3 (2). https://doi.org/10.16889/isomerdesign-6 #3-MMC NMR
Ferreira, B; da Silva, DD; Carvalho, F; de Lourdes Bastos, M; Carmo, H. The novel psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone): A review. Forensic Sci. Int., 1 Feb 2019, 295, 54–63. 624 kB. https://doi.org/10.1016/j.forsciint.2018.11.024 #3-MMC
Simmons, SJ; Leyrer-Jackson, JM; Oliver, CF; Hicks, C; Muschamp, JW; Rawls, SM; Olive, MF. DARK classics in chemical neuroscience: Cathinone-derived psychostimulants. ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2379–2394. 1.6 MB. https://doi.org/10.1021/acschemneuro.8b00147 #3-MMC
Anon. Separation and identification of methyl-methcathinones. Hungarian Institute for Forensic Sciences, 11 Mar 2011. 529 kB. #3-MMC GC,LC,MS,IR,UV,TLC
Luethi, D; Liechti, ME. Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics. Int. J. Neuropsychoph., 1 Oct 2018, 21 (10), 926–931. 254 kB. https://doi.org/10.1093/ijnp/pyy047 #S1 Cathinones 3-MMC
Kronstrand, R; Guerrieri, D; Vikingsson, S; Wohlfarth, A; Gréen, H. Fatal poisonings associated with new psychoactive substances. In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 495–541. 477 kB. https://doi.org/10.1007/164_2018_110 #3-MMC
Kraemer, M; Boehmer, A; Madea, B; Maas, A. Death cases involving certain new psychoactive substances: A review of the literature. Forensic Sci. Int., 1 May 2019, 298, 186–267. 6.7 MB. https://doi.org/10.1016/j.forsciint.2019.02.021 #3-MMC
Walther, D; Shalabi, AR; Baumann, MH; Glennon, RA. Systematic structure–activity studies on selected 2-, 3-, and 4-monosubstituted synthetic methcathinone analogs as monoamine transporter releasing agents. ACS Chem. Neurosci., 16 Jan 2019, 10 (1), 740–745. 498 kB. https://doi.org/10.1021/acschemneuro.8b00524 #3c NMR,other
Bork, W; Dahlenburg, R; Gimbel, M; Jacobsen-Bauer, A; Zörntlein, S. Herleitung Von Grenzwerten Der „nicht Geringen Menge“ Im Sinne Des Btmg. Toxichem Krimtech, 1 Jan 2019, 86 (1), 5–91. 4.4 MB. #CA-024
Nishimura, Y; Tanaka, S; Ikeda, H; Yamazaki, Y. Study of method for identifying regioisomers of controlled drugs. JCCL, 1 Dec 2015, (55), 65–85. 707 kB. #3-MMC Japanese, English abstract GC,MS,UV
Hägele, JS; Basrak, M; Schmid, MG. Enantioselective separation of novel psychoactive substances using a Lux® AMP 3 μm column and HPLC-UV. J. Pharm. Biomed. Anal., 5 Feb 2020, 179, 112967. 3.6 MB. https://doi.org/10.1016/j.jpba.2019.112967 #P2 LC
Clancy, L; Philp, M; Shimmon, R; Fu, S. Development and validation of a color spot test method for the presumptive detection of 25-NBOMe compounds. Drug Test. Anal., 19 Aug 2020, 13 (5), 929-943. 11.3 MB. https://doi.org/10.1002/dta.2905 #3-methylmethcathinone
Rouxinol, D; Carmo, H; Carvalho, F; de Lourdes Bastos, M; da Silva, DD. Pharmacokinetics, pharmacodynamics, and toxicity of the new psychoactive substance 3,4-dimethylmethcathinone (3,4-DMMC). Forensic Toxicol., 1 Jan 2020, 38 (1), 15–29. 1.3 MB. https://doi.org/10.1007/s11419-019-00494-x #3-MMC
Hulme, MC; Hayatbakhsh, A; Brignall, RM; Gilbert, N; Costello, A; Schofield, CJ; Williamson, DC; Kemsley, EK; Sutcliffe, OB; Mewis, RE. Detection, discrimination and quantification of amphetamine, cathinone and nor-ephedrine regioisomers using benchtop 1H and 19F nuclear magnetic resonance spectroscopy. Magn. Reson. Chem., 20 Apr 2021, n/a. 1.9 MB. https://doi.org/10.1002/mrc.5156 #2b GC,MS,NMR,IR,TLC